Angiogenesis
During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
A3001 PCI-32765 (Ibrutinib)4 CitationSummary: Bruton's tyrosine kinase (BTK) inhibitor
-
A4507 KC7F2Summary: HIF-1α inhibitor
-
A4509 PX 12Target: TrxSummary: Trx-1 inhibitor
-
A4506 DMOGTarget: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)Summary: Competitive HIF-PH inhibitor, cell-permeable
-
A8229 ML161Target: Protease-Activated ReceptorsSummary: PAR1 inhibitor
-
A8233 DMXAA (Vadimezan)2 CitationTarget: DT-diaphorasesSummary: Tumnor vascular disrupting agent, apoptosis inducer
-
B6106 Daprodustat(GSK1278863)Summary: HIF-prolyl hydroxylase inhibitor
-
B6185 ACP-196Target: BTKSummary: irreversible BTK inhibitor
-
B5851 FG2216Target: Pyruvate dehydrogenases (PDH)Summary: HIF-prolyl hydroxylase inhibitor
-
B5952 LFM-A13Summary: BTK-specific tyrosine kinase inhibitor